KRTAP2-2 inhibitors refer to a chemical class targeting the Keratin-Associated Protein 2-2 (KRTAP2-2), a member of the keratin-associated protein family. KRTAP proteins play a critical role in hair fiber structure, as they are involved in cross-linking keratins to form the dense, fibrous protein matrix found in hair and other keratinized tissues. KRTAP2-2 inhibitors are designed to modulate the activity or expression of this specific protein, leading to changes in the biochemical processes that regulate hair keratinization and the integrity of the hair shaft. These inhibitors work by interfering with the protein-protein interactions or the biochemical pathways that influence KRTAP2-2's structural role, thereby potentially altering the formation of the hair's keratin matrix.
The molecular mechanisms underlying KRTAP2-2 inhibition can vary depending on the inhibitor's design, but they generally involve binding to KRTAP2-2 or associated cofactors, preventing their usual function. This inhibition may result from direct binding to the active sites of the protein or by modulating upstream pathways that control its expression. By targeting KRTAP2-2, these compounds may influence post-translational modifications or disrupt the cross-linking of keratins, thus impacting the protein's structural role within hair. The specificity of KRTAP2-2 inhibitors is critical, as it allows for focused modulation of KRTAP2-2 activity without broad effects on other keratin-associated proteins, which could lead to unintended changes in keratinized structures throughout the body. The development and study of these inhibitors are essential for understanding the detailed molecular biology of keratin-associated processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $68.00 $210.00 $780.00 $1880.00 | 19 | |
Sulfhydryl-reactive compound that can modify cysteine residues, potentially affecting KRTAP2-2's ability to form disulfide bonds, which are crucial for its function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
N-linked glycosylation inhibitor that can affect protein folding and stability, possibly impacting KRTAP2-2's structure and function. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $55.00 $179.00 $345.00 | 1 | |
Heavy metal that can replace zinc in zinc-finger domains of DNA-binding proteins, possibly affecting protein-protein interactions involving KRTAP2-2. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $40.00 | 4 | |
Compound that can bind to vicinal thiols, potentially altering the function of KRTAP2-2 if it relies on such groups for its stability or interactions. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Folate pathway inhibitor that can affect cell proliferation and protein synthesis, possibly impacting KRTAP2-2's expression levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Protein synthesis inhibitor that can prevent the synthesis of KRTAP2-2. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Transcription inhibitor that can suppress the transcription of KRTAP2-2 gene. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $106.00 $765.00 | 3 | |
Induces oxidative stress which can affect protein folding and stability, possibly impacting KRTAP2-2. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that can lead to the accumulation of misfolded proteins, potentially including KRTAP2-2. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Lysosomotropic agent that can alter the endosomal/lysosomal system, potentially affecting the degradation pathways for KRTAP2-2. | ||||||